In the early steps of cancer formation, timing matters
Using powerful, high-resolution microscopy, a Yale-led team of scientists has revealed the very first cancer-triggering physical changes in mouse skin cells. (Source: Yale Science and Health News)
Source: Yale Science and Health News - May 3, 2024 Category: Universities & Medical Training Source Type: news
MicroRNAs Predict Pancreatic Cancer Risk Years in Advance MicroRNAs Predict Pancreatic Cancer Risk Years in Advance
Expression levels of several microRNAs in plasma samples can help predict the onset of pancreatic cancer up to 5 years prior to clinical diagnosis.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 3, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Clinical Summary Source Type: news
Drug targeting RNA modifications shows promise for treating neuroblastoma
Neuroblastoma is a common pediatric cancer that originates in developing nerve cells outside the brain. While increasingly intensive treatments have improved the survival of patients with high-risk neuroblastoma, currently more than 40% of patients do not survive.
New research from the University of Chicago shows the potential for a promising new approach to treating neuroblastoma by targeting RNA modifications associated with the disease. (Source: World Pharma News)
Source: World Pharma News - May 3, 2024 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
What's Driving Higher Breast Cancer Deaths in Black Women? What's Driving Higher Breast Cancer Deaths in Black Women?
Despite improvements in breast cancer screening and treatment, Black women experience higher death rates and more aggressive forms of the disease than White women.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 3, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
The changing picture of disease — living longer may not mean living healthier
Caseloads of cancer and other illnesses of ageing are forecast to rise steeply in lower income countries (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 3, 2024 Category: Pharmaceuticals Source Type: news
Telix Pharmaceuticals Bolsters Oncology Portfolio
Telix Pharmaceuticals Ltd. (AU:TLX) has released an update. Telix Pharmaceuticals Ltd has finalized the acquisition of QSAM Biosciences, acquiring ...#qsambiosciences (Source: Reuters: Health)
Source: Reuters: Health - May 2, 2024 Category: Consumer Health News Source Type: news
Fresh and Frozen Embryo Transfers May Increase Risk of Childhood Leukemia
(MedPage Today) -- While overall cancer risk was no different for children born after fertility treatments compared with those naturally conceived, frozen or fresh embryo transfer did appear to increase risk of leukemia, according to a French cohort... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 2, 2024 Category: Endocrinology Source Type: news
Terrifying time-lapse video reveals how a tiny dark blotch can morph into stage 4 skin cancer
Doctors in Virginia created the clip to reveal the warning signs of skin cancer ahead of the summer season. They also hope to urge more people to protect themselves in the sun. (Source: the Mail online | Health)
Source: the Mail online | Health - May 2, 2024 Category: Consumer Health News Source Type: news
It May Be Safe to Extend Time Between Colonoscopy Screenings, Study Says
(MedPage Today) -- Patients with no family history of colorectal cancer (CRC) whose first colonoscopy was negative may be able to delay their next screening for 15 years rather than the currently recommended 10 years, a Swedish register-based cohort... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - May 2, 2024 Category: American Health Source Type: news
Novartis bets on actinium RLT with $1B Mariana Oncology acquisition
Novartis has entered into an agreement to acquire Mariana Oncology, a preclinical-stage biotechnology company that develops novel radioligand therapies (RLTs) for cancer.
Watertown, MA-based Mariana Oncology's portfolio crosses a range of solid tumor indications such as breast, prostate, and lung cancer and includes development candidate MC-339, an actinium-based RLT being investigated in small cell lung cancer, according to Novartis. In September 2023, Mariana announced $175 million in Series B financing from Atlas Venture, Access Biotechnology, RA Capital Management, Nextech Invest, Surveyor Capital, and Eli Lilly and C...
Source: AuntMinnie.com Headlines - May 2, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Radiation Oncology Source Type: news
Context Therapeutics gets $100M financing deal and a key FDA approval
Context Therapeutics is advancing its experimental therapy being developed to treat solid tumors in gynecologic and testicular cancers. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 2, 2024 Category: Biotechnology Authors: John George Source Type: news
Exclusive: Thyme Care launches virtual palliative care program, appoints medical director
Dr. Julia Frydman will be the oncology-focused company ' s first medical director for palliative care. She will oversee its new Enhanced Supportive Care program. (Source: mobihealthnews)
Source: mobihealthnews - May 2, 2024 Category: Information Technology Source Type: news
Philips will pay $1.1billion to people who said company's $1,600 sleep apnea machines gave them CANCER
CPAP maker Philips reached a $1.1 billion settlement deal over claims from thousands of Americans who blame their cancers on degrading foam and toxic gases emitted by the machines. (Source: the Mail online | Health)
Source: the Mail online | Health - May 2, 2024 Category: Consumer Health News Source Type: news
BridgeBio Pharma spins out cancer-focused unit with three drugs, $200 million
The move should allow BridgeBio Pharma to concentrate on its heart failure drug, which could win FDA approval in November, as the spinout's cancer drugs enter clinical trials. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 2, 2024 Category: Biotechnology Authors: Ron Leuty Source Type: news
Neoadjuvant Chemohormonal Therapy Aids Locally Advanced Prostate Cancer
THURSDAY, May 2, 2024 -- For patients with locally advanced prostate cancer, neoadjuvant chemohormonal therapy (NCHT) is beneficial for biochemical progression-free survival (bPFS), according to a study published online May 1 in The Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 2, 2024 Category: Pharmaceuticals Source Type: news
